product summary
Loading...
company name :
OriGene
product type :
antibody
product name :
UNG Rabbit Polyclonal Antibody
catalog :
TA336670
quantity :
100 µg
price :
403 USD
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human
application :
western blot, immunohistochemistry
more info or order :
product information
SKU :
TA336670
Category :
Antibodies
Sub-Category :
Primary Antibodies
Name :
UNG Rabbit Polyclonal Antibody
Description :
Rabbit Polyclonal UNG Antibody
Size :
100 µg
Price US :
403 USD
Delivery Time US :
5 Days
Symbol :
UNG
Uniprot ID :
P13051
Accn :
NM_080911
Clonality :
Polyclonal
Host :
Rabbit
Applications :
IHC, WB
Reactivity :
Human, Mouse, Rabbit, Rat
more info or order :
company information

OriGene
9620 Medical Center Dr., Suite 200
Rockville, MD 20850
Rockville, MD 20850
custsupport@origene.com
https://www.origene.com1-888-267-4436
headquarters: USA
OriGene Technologies, Inc. is a gene centric life sciences company dedicated to support biomedical scientists in gene functions and drug discovery. OriGene’s novel product line includes the world’s largest collections of cDNA clones (TrueClone and TrueORF), shRNA (HuSH-29), purified human recombinant proteins, high quality TrueMAB™ monoclonal antibodies to human proteins, 100,000 highly validated human tissues, and qPCR arrays. OriGene also provides a broad range of antibody validation products including genome-wide tagged antigen standards and extensive IHC slides derived from our tissue collection. OriGene is a Luminex Certified Partner™ and offers multiplexed immunoassays and multiplexed assays for a broad range of biomarkers.
related products
browse more products
- TRAF5 Mouse Monoclonal Antibody [Clone ID: 55A219] | TA336671
- IL23 Receptor (IL23R) Rabbit Polyclonal Antibody | TA336672
- Noxa (PMAIP1) Mouse Monoclonal Antibody [Clone ID: 114C307.1] | TA336673
- AKT3 Mouse Monoclonal Antibody [Clone ID: 66C1247] | TA336674
- CD31 (PECAM1) Rat Monoclonal Antibody [Clone ID: MEC13.3] | TA336675
questions and comments